Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Baran

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Biology|November 27, 2021
Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus-Preliminary DataAnna Baran, Julia Nowowiejska, Tomasz W Kamiński, et al.
International Journal of Molecular Sciences|March 28, 2024
A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on Treatment, Etiopathogenesis, Diagnosis, and Clinical PresentationMaciej Naumowicz, Stefan Modzelewski, Angelika Macko, et al.
Postepy Dermatologii I Alergologii|June 1, 2022
Great hopes or disappointment - a survey-based study on patients' and doctors' perception of telemedicine during the COVID-19 pandemic in PolandAnna Stepaniuk, Cezary Pawlukianiec, Magdalena Krawiel, et al.
Lipids|July 9, 2019
Adipocyte Fatty Acid-Binding Protein as a Novel Marker of Psoriasis and Clinical Response to AcitretinAnna Baran, Paulina Kiluk, Magdalena Świderska, et al.
Dermatology and Therapy|September 1, 2022
Maskne-Dermatosis of a Pandemic. A Survey on the Impact of PPE on Facial Skin Among HCW and N-HCW in PolandIzabela U Malczynska, Gabriela Krych, Anna Baran, et al.
Journal of Clinical Medicine|April 1, 2020
Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary DataJulita Anna Krahel, Anna Baran, Tomasz W Kamiński, et al.
Dermatology and Therapy|August 11, 2023
Tumor Necrosis Factor (TNF) α, Endothelin (ET) 1 and α1-Acid Glycoprotein (AGP) as Potential Urine and Serum Markers of Metabolic Complications in Psoriasis?Julia Nowowiejska, Anna Baran, Justyna M Hermanowicz, et al.
Przeglad Epidemiologiczny|February 22, 2017
Clinical and epidemiological assessment of patients hospitalized for primary and recurrent erysipelasDorota Kozłowska, Hanna Myśliwiec, Paulina Kiluk, et al.
Metabolites|July 27, 2022
Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis-Preliminary DataAnna Baran, Anna Stepaniuk, Paulina Kiluk, et al.
Przeglad Epidemiologiczny|October 29, 2020
What do you know about sexually transmitted infections? Survey concerning knowledge and risky behaviors among students of Białystok universitiesPaulina Grabowska, Marta Lewoc, Olivia Jakubowicz-Zalewska, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Biology|November 27, 2021
Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus-Preliminary DataAnna Baran, Julia Nowowiejska, Tomasz W Kamiński, et al.
International Journal of Molecular Sciences|March 28, 2024
A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on Treatment, Etiopathogenesis, Diagnosis, and Clinical PresentationMaciej Naumowicz, Stefan Modzelewski, Angelika Macko, et al.
Postepy Dermatologii I Alergologii|June 1, 2022
Great hopes or disappointment - a survey-based study on patients' and doctors' perception of telemedicine during the COVID-19 pandemic in PolandAnna Stepaniuk, Cezary Pawlukianiec, Magdalena Krawiel, et al.
Lipids|July 9, 2019
Adipocyte Fatty Acid-Binding Protein as a Novel Marker of Psoriasis and Clinical Response to AcitretinAnna Baran, Paulina Kiluk, Magdalena Świderska, et al.
Dermatology and Therapy|September 1, 2022
Maskne-Dermatosis of a Pandemic. A Survey on the Impact of PPE on Facial Skin Among HCW and N-HCW in PolandIzabela U Malczynska, Gabriela Krych, Anna Baran, et al.
Journal of Clinical Medicine|April 1, 2020
Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary DataJulita Anna Krahel, Anna Baran, Tomasz W Kamiński, et al.
Dermatology and Therapy|August 11, 2023
Tumor Necrosis Factor (TNF) α, Endothelin (ET) 1 and α1-Acid Glycoprotein (AGP) as Potential Urine and Serum Markers of Metabolic Complications in Psoriasis?Julia Nowowiejska, Anna Baran, Justyna M Hermanowicz, et al.
Przeglad Epidemiologiczny|February 22, 2017
Clinical and epidemiological assessment of patients hospitalized for primary and recurrent erysipelasDorota Kozłowska, Hanna Myśliwiec, Paulina Kiluk, et al.
Metabolites|July 27, 2022
Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis-Preliminary DataAnna Baran, Anna Stepaniuk, Paulina Kiluk, et al.
Przeglad Epidemiologiczny|October 29, 2020
What do you know about sexually transmitted infections? Survey concerning knowledge and risky behaviors among students of Białystok universitiesPaulina Grabowska, Marta Lewoc, Olivia Jakubowicz-Zalewska, et al.
Pageof 9